ConductScience.org, home

Paper69269

Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease.

Greer MA and 2 others. N Engl J Med, 1977. Cited by 69 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease. Papers, record 69269. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/69269

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease.
PubMed
Journal
N Engl J Med
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
3
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Greer MAM A
2Kammer HH
3Bouma DJD J

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antithyroid AgentsMajor topic
Graves DiseaseMajor topic
Administration, Oral
Adolescent
Adult
Child
Female
Humans
Male
Methimazole
Middle Aged
Prognosis
Propylthiouracil
Remission, Spontaneous
Thyroidectomy
Thyroxine
Time Factors
Triiodothyronine

Source PubMed

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
39,407,446Long-Term Antithyroid Drug Therapy in Smoldering or Fluctuating-Type Graves' Hyperthyroidism with Potassium Iodide.Endocrinol Metab (Seoul)2024https://conductscience.org/library/papers/39407446PubMed
35,088,381Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves' disease: a systematic scoping review.J Endocrinol Invest2022https://conductscience.org/library/papers/35088381PubMed
25,089,127Pediatric Graves' disease: management in the post-propylthiouracil Era.Int J Pediatr Endocrinol2014https://conductscience.org/library/papers/25089127PubMed
7,560,811Simple and reliable method for predicting the remission of Graves' disease: revised triiodothyronine-suppression test, indexed by serum thyroxine.J Endocrinol Invest1995https://conductscience.org/library/papers/7560811PubMed
7,376,643Single daily dose methimazole treatment of hyperthyroidism.West J Med1980https://conductscience.org/library/papers/7376643PubMed
6,199,072Are antithyroid drugs immunosuppressive?Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6199072PubMed
6,172,233Clinical pharmacokinetics of antithyroid drugs.Clin Pharmacokinet1981https://conductscience.org/library/papers/6172233PubMed
3,840,555[Indications for conservative and operative therapy of thyroid autonomy and Basedow hyperthyroidism from the internal medicine viewpoint].Langenbecks Arch Chir1985https://conductscience.org/library/papers/3840555PubMed
3,302,147Stopping and restarting medications in the perioperative period.J Gen Intern Med1987https://conductscience.org/library/papers/3302147PubMed
2,892,877Thyroid stimulating immunoglobulin bioactivity during carbimazole therapy as measured by the cytochemical bioassay.J Endocrinol Invest1987https://conductscience.org/library/papers/2892877PubMed
2,573,625Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year.J Endocrinol Invest1989https://conductscience.org/library/papers/2573625PubMed
2,564,286Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease.BMJ1989https://conductscience.org/library/papers/2564286PubMed
2,038,087Remission of Graves' disease with hyperthyroidism by a combination of glucocorticoids and antithyroid drugs.J Natl Med Assoc1991https://conductscience.org/library/papers/2038087PubMed
1,478,841Management of patients with diffuse toxic goitre in Ireland, a country with low iodine intake.Ir J Med Sci1992https://conductscience.org/library/papers/1478841PubMed
1,283,984Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission.J Endocrinol Invest1992https://conductscience.org/library/papers/1283984PubMed
90,689Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?J Endocrinol Invest1978https://conductscience.org/library/papers/90689PubMed
77,148Selection of treatment in the management of thyrotoxicosis in childhood and adolescence.Ann Surg1978https://conductscience.org/library/papers/77148PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/69269

GET https://conductscience.org/api/papers/v1/69269/authors